190 related articles for article (PubMed ID: 28801636)
1. Inhibition of hypoxic response decreases stemness and reduces tumorigenic signaling due to impaired assembly of HIF1 transcription complex in pancreatic cancer.
McGinn O; Gupta VK; Dauer P; Arora N; Sharma N; Nomura A; Dudeja V; Saluja A; Banerjee S
Sci Rep; 2017 Aug; 7(1):7872. PubMed ID: 28801636
[TBL] [Abstract][Full Text] [Related]
2. Downregulation of Sp1 by Minnelide leads to decrease in HSP70 and decrease in tumor burden of gastric cancer.
Arora N; Alsaied O; Dauer P; Majumder K; Modi S; Giri B; Dudeja V; Banerjee S; Von Hoff D; Saluja A
PLoS One; 2017; 12(2):e0171827. PubMed ID: 28192510
[TBL] [Abstract][Full Text] [Related]
3. Minnelide Inhibits Androgen Dependent, Castration Resistant Prostate Cancer Growth by Decreasing Expression of Androgen Receptor Full Length and Splice Variants.
Isharwal S; Modi S; Arora N; Uhlrich C; Giri B; Barlass U; Soubra A; Chugh R; Dehm SM; Dudeja V; Saluja A; Banerjee S; Konety B
Prostate; 2017 May; 77(6):584-596. PubMed ID: 28144973
[TBL] [Abstract][Full Text] [Related]
4. CD133+ tumor initiating cells in a syngenic murine model of pancreatic cancer respond to Minnelide.
Banerjee S; Nomura A; Sangwan V; Chugh R; Dudeja V; Vickers SM; Saluja A
Clin Cancer Res; 2014 May; 20(9):2388-99. PubMed ID: 24634377
[TBL] [Abstract][Full Text] [Related]
5. LB-1 Exerts Antitumor Activity in Pancreatic Cancer by Inhibiting HIF-1α and Stat3 Signaling.
Niu F; Li Y; Lai FF; Ni L; Ji M; Jin J; Yang HZ; Wang C; Zhang DM; Chen XG
J Cell Physiol; 2015 Sep; 230(9):2212-23. PubMed ID: 25655308
[TBL] [Abstract][Full Text] [Related]
6. Impaired Synthesis of Stromal Components in Response to Minnelide Improves Vascular Function, Drug Delivery, and Survival in Pancreatic Cancer.
Banerjee S; Modi S; McGinn O; Zhao X; Dudeja V; Ramakrishnan S; Saluja AK
Clin Cancer Res; 2016 Jan; 22(2):415-25. PubMed ID: 26405195
[TBL] [Abstract][Full Text] [Related]
7. Triptolide-induced cell death in pancreatic cancer is mediated by O-GlcNAc modification of transcription factor Sp1.
Banerjee S; Sangwan V; McGinn O; Chugh R; Dudeja V; Vickers SM; Saluja AK
J Biol Chem; 2013 Nov; 288(47):33927-33938. PubMed ID: 24129563
[TBL] [Abstract][Full Text] [Related]
8. Triptolide reverses hypoxia-induced epithelial-mesenchymal transition and stem-like features in pancreatic cancer by NF-κB downregulation.
Liu L; Salnikov AV; Bauer N; Aleksandrowicz E; Labsch S; Nwaeburu C; Mattern J; Gladkich J; Schemmer P; Werner J; Herr I
Int J Cancer; 2014 May; 134(10):2489-503. PubMed ID: 24615157
[TBL] [Abstract][Full Text] [Related]
9. Minnelide effectively eliminates CD133(+) side population in pancreatic cancer.
Nomura A; McGinn O; Dudeja V; Sangwan V; Saluja AK; Banerjee S
Mol Cancer; 2015 Nov; 14():200. PubMed ID: 26597727
[TBL] [Abstract][Full Text] [Related]
10. miR-204 mediated loss of Myeloid cell leukemia-1 results in pancreatic cancer cell death.
Chen Z; Sangwan V; Banerjee S; Mackenzie T; Dudeja V; Li X; Wang H; Vickers SM; Saluja AK
Mol Cancer; 2013 Sep; 12(1):105. PubMed ID: 24025188
[TBL] [Abstract][Full Text] [Related]
11. "Heat shock protein 70 in pancreatic diseases: Friend or foe".
Giri B; Sethi V; Modi S; Garg B; Banerjee S; Saluja A; Dudeja V
J Surg Oncol; 2017 Jul; 116(1):114-122. PubMed ID: 28543919
[TBL] [Abstract][Full Text] [Related]
12. A preclinical evaluation of Minnelide as a therapeutic agent against pancreatic cancer.
Chugh R; Sangwan V; Patil SP; Dudeja V; Dawra RK; Banerjee S; Schumacher RJ; Blazar BR; Georg GI; Vickers SM; Saluja AK
Sci Transl Med; 2012 Oct; 4(156):156ra139. PubMed ID: 23076356
[TBL] [Abstract][Full Text] [Related]
13. Triptolide suppresses proliferation, hypoxia-inducible factor-1α and c-Myc expression in pancreatic cancer cells.
Ding X; Zhou X; Jiang B; Zhao Q; Zhou G
Mol Med Rep; 2015 Sep; 12(3):4508-4513. PubMed ID: 26094625
[TBL] [Abstract][Full Text] [Related]
14. Inactivation of Cancer-Associated-Fibroblasts Disrupts Oncogenic Signaling in Pancreatic Cancer Cells and Promotes Its Regression.
Dauer P; Zhao X; Gupta VK; Sharma N; Kesh K; Gnamlin P; Dudeja V; Vickers SM; Banerjee S; Saluja A
Cancer Res; 2018 Mar; 78(5):1321-1333. PubMed ID: 29259015
[TBL] [Abstract][Full Text] [Related]
15. Pre-clinical evaluation of Minnelide as a therapy for acute myeloid leukemia.
Giri B; Gupta VK; Yaffe B; Modi S; Roy P; Sethi V; Lavania SP; Vickers SM; Dudeja V; Banerjee S; Watts J; Saluja A
J Transl Med; 2019 May; 17(1):163. PubMed ID: 31109340
[TBL] [Abstract][Full Text] [Related]
16. Hypoxia Promotes Pancreatic Cancer Cell Dedifferentiation to Stem-Like Cell Phenotypes With High Tumorigenic Potential by the HIF-1α/Notch Signaling Pathway.
Mu R; Zou YK; Tu K; Wang DB; Tang D; Yu Z; Zhao L
Pancreas; 2021 May-Jun 01; 50(5):756-765. PubMed ID: 34016895
[TBL] [Abstract][Full Text] [Related]
17. The novel hypoxic cytotoxin, TX-2098 has antitumor effect in pancreatic cancer; possible mechanism through inhibiting VEGF and hypoxia inducible factor-1α targeted gene expression.
Miyake K; Nishioka M; Imura S; Batmunkh E; Uto Y; Nagasawa H; Hori H; Shimada M
Exp Cell Res; 2012 Aug; 318(13):1554-63. PubMed ID: 22472348
[TBL] [Abstract][Full Text] [Related]
18. Minnelide: a novel therapeutic that promotes apoptosis in non-small cell lung carcinoma in vivo.
Rousalova I; Banerjee S; Sangwan V; Evenson K; McCauley JA; Kratzke R; Vickers SM; Saluja A; D'Cunha J
PLoS One; 2013; 8(10):e77411. PubMed ID: 24143232
[TBL] [Abstract][Full Text] [Related]
19. RER1 enhances carcinogenesis and stemness of pancreatic cancer under hypoxic environment.
Chen S; Zhang J; Chen J; Wang Y; Zhou S; Huang L; Bai Y; Peng C; Shen B; Chen H; Tian Y
J Exp Clin Cancer Res; 2019 Jan; 38(1):15. PubMed ID: 30630537
[TBL] [Abstract][Full Text] [Related]
20. The ST6Gal-I sialyltransferase protects tumor cells against hypoxia by enhancing HIF-1α signaling.
Jones RB; Dorsett KA; Hjelmeland AB; Bellis SL
J Biol Chem; 2018 Apr; 293(15):5659-5667. PubMed ID: 29475939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
